Proteomics

Dataset Information

0

A multi-omics approach unravels new toxins with potential antimicrobial, antiviral and antitumoral activities in the venom of Acanthoscurria rondoniae


ABSTRACT: The Araneae order is considered one of the most successful group among venomous animals in the world. An important factor for this success is the production of venoms, a refined biological fluid rich in proteins, short peptides and cysteine-rich peptides (CRPs). These toxins may present pharmacologically relevant biological actions, as antimicrobial, antiviral and anticancer activities, for instance. Therefore, there is an increasing interest in the exploration of venom toxins for therapeutic reasons, such as drug development. However, the process of peptide sequencing and mainly the evaluation of potential biological activities of these peptides is laborious, considering the low yield of venom extraction and the high variability of toxins present in spider venoms. Here we show a robust methodology for identification, sequencing, and initial screening of potential bioactive peptides found in the venom of Acanthoscurria rondoniae. This methodology consists in a multi-omics approach involving proteomics, peptidomics and transcriptomics analyses allied to in silico predictions of antibacterial, antifungal, antiviral and anticancer activities. Through the application of this strategy, a total of 92,889 venom gland transcripts were assembled and 84 novel toxins were identified at the protein level, including 7 short peptides and 10 fully sequenced CRPs (belonging to 7 toxin families). In silico analysis revealed that 7 CRPs families have potential antimicrobial or antiviral activities, while 2 CRPs and four short peptides are potentially anticancer. Taken together, our results demonstrate an effective multi-omics strategy for the discovery of new toxins and in silico screening of potential bioactivities. This strategy may be useful in toxin discovery, as well as in the screening of activities for the vast diversity of molecules produced by venomous animals.

INSTRUMENT(S): Synapt MS, Q Exactive

ORGANISM(S): Acanthoscurria Rondoniae

TISSUE(S): Venom, Venom Gland

SUBMITTER: Alexandre Keiji Tashima  

LAB HEAD: Alexandre Keiji Tashima

PROVIDER: PXD019343 | Pride | 2020-07-20

REPOSITORIES: Pride

Dataset's files

Source:
Action DRS
20141110_AR_ADH_R001.raw.rar Raw
20141110_AR_ADH_R002.raw.rar Raw
20141110_AR_ADH_R003.raw.rar Raw
20141110_Ar_ADH2.mgf Mgf
201805_Arondoniae_QE_digest.mgf Mgf
Items per page:
1 - 5 of 24
altmetric image

Publications

A Multiomics Approach Unravels New Toxins With Possible <i>In Silico</i> Antimicrobial, Antiviral, and Antitumoral Activities in the Venom of <i>Acanthoscurria rondoniae</i>.

Câmara Guilherme A GA   Nishiyama-Jr Milton Y MY   Kitano Eduardo S ES   Oliveira Ursula C UC   da Silva Pedro I PI   Junqueira-de-Azevedo Inácio L IL   Tashima Alexandre K AK  

Frontiers in pharmacology 20200717


The <i>Araneae</i> order is considered one of the most successful groups among venomous animals in the world. An important factor for this success is the production of venoms, a refined biological fluid rich in proteins, short peptides and cysteine-rich peptides (CRPs). These toxins may present pharmacologically relevant biological actions, as antimicrobial, antiviral and anticancer activities, for instance. Therefore, there is an increasing interest in the exploration of venom toxins for therap  ...[more]

Similar Datasets

2023-06-01 | PXD039980 | Pride
2024-08-29 | PXD048264 | Pride
2023-02-08 | PXD033502 | Pride
2024-06-22 | PXD046399 | Pride
2018-11-30 | PXD011684 | Pride
2018-11-30 | PXD011685 | Pride
2015-01-26 | PXD001343 | Pride
2024-05-24 | PXD046872 | Pride
2022-10-20 | PXD013149 | Pride
2019-02-25 | PXD010962 | Pride